Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGOâ„¢ (dasatinib) Tablets, in the US
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in partnership with Handa Therapeutics, LLC, and will be exclusively available through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results